News & Media

Kane Biotech Receives $2.7 Million USD United States Department of Defense Award of DispersinB®

Kane Biotech, Winnipeg based company, received the U.S. Department of Defense’s (“DoD”) Medical Technology Enterprise Consortium Research Project Award (“MTEC Award”) for its proposal entitled "Clinical evaluation of DispersinB® to treat biofilm mediated antimicrobial resistance in non healing chronic wound".

The MTEC Award will provide approximately $2.7 million USD in non-dilutive funding for the continued clinical development of the Company's DispersinB® to treat biofilm-mediated antimicrobial resistance in non-healing chronic wounds.

 “This award is transformative for our Human Health business and will support our work to identify the product’s optimal development and regulatory approval path”, added Marc Edwards.

READ MORE

 

 

Back